In support of our results, a number of studies have demonstrated a tumour suppressive role of NCOR2 in cancers, such as LUAD, head and neck squamous cell carcinoma, non-Hodgkin lymphoma and osteosarcoma14–17. The gene discussed is NCOR2; the disease is non-Hodgkin lymphoma.